Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferase

Mice lacking phosphatidylethanolamine N-methyltransferase (PEMT) are protected from high-fat diet (HFD)-induced obesity and insulin resistance. However, these mice develop severe nonalcoholic fatty liver disease (NAFLD) when fed the HFD, which is mainly due to inadequate secretion of VLDL particles....

Descripción completa

Detalles Bibliográficos
Autores principales: van der Veen, Jelske N., Lingrell, Susanne, Gao, Xia, Takawale, Abhijit, Kassiri, Zamaneh, Vance, Dennis E., Jacobs, René L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392742/
https://www.ncbi.nlm.nih.gov/pubmed/28159867
http://dx.doi.org/10.1194/jlr.M070631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392742/
https://www.ncbi.nlm.nih.gov/pubmed/28159867
http://dx.doi.org/10.1194/jlr.M070631

Ejemplares similares